Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

3
Player Avatar ross812 (34.54) Submitted: 3/5/2010 8:32:40 AM : Underperform Start Price: $10.15 JAZZ Score: -1,431.08

Garbage. Garbage. Garbage!!! See what happens if they fail a drug trial!

Featured Broker Partners


Advertisement